Cortico Steroids Flashcards

(136 cards)

1
Q

Clinical Indications for Use of
Inhaled Corticosteroids

____ _ ____
COPD

A

Step 2 asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical Indications for Use of
Inhaled Corticosteroids

Step 2 asthma
_____

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical Indications for Use of
Inhaled Corticosteroids

Intranasal aerosol agents:
Management of ? and perennial allergic and
nonallergic rhinitis

A

seasonal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical Indications for Use of
Inhaled Corticosteroids

Intranasal aerosol agents:
Management of seasonal and ? ? and
nonallergic rhinitis

A

perennial allergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical Indications for Use of
Inhaled Corticosteroids

Intranasal aerosol agents:
Management of seasonal and perennial allergic and
____ ______?

A

nonallergic rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most common type of asthma

A

Allergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Allergic Asthma

Can be treated with ________
commonly known as allergy shots because
the exact triggering antigen is known.

A

immunotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Allergic Asthma

Can be treated with immunotherapy
commonly known as ____ ____ because
the exact triggering antigen is known.

A

allergy shots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Allergic Asthma

Can be treated with immunotherapy
commonly known as allergy shots because
the exact triggering _____ is known.

A

antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Allergic Asthma

Can be treated with immunotherapy
commonly known as allergy shots because
the exact triggering antigen is _____.

A

KNOWN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Non-allergic asthma:
Triggered by:

_____ ___
Exercise
Stress
Infection

A

Cold air

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Non-allergic asthma:
Triggered by:

Cold air
______
Stress
Infection

A

Exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Non-allergic asthma:
Triggered by:

Cold air
Exercise
_____
Infection

A

Stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Non-allergic asthma:
Triggered by:

Cold air
Exercise
Stress
______

A

Infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Non-allergic asthma:

No ____ ______ is identified.
No immune response is involved.

A

Specific Antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Non-allergic asthma:

No specific antigen is identified.
No _______ response is involved.

A

Immune

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

___-____ asthma:

No specific antigen is identified.
No immune response is involved.

A

Non-allergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Phases of the Inflam Response

A

Early Phase & Late Phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Phases of the Inflam Response

Early-phase response:
Local vasodilatation
_______ _______ ________
Redness

A

Increased vascular permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Phases of the Inflam Response

Early-phase response:
_____ _______
Increased vascular permeability
Redness

A

Local vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Phases of the Inflam Response

____-____response:
Local vasodilatation
Increased vascular permeability
Redness

A

Early-phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Phases of the Inflam Response

Early-phase response:
Local vasodilatation
Increased vascular permeability
_______

A

Redness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Phases of the Inflam Response

Early-phase response:
Local vasodilatation
______ vascular permeability
Redness

A

Increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Phases of the Inflam Response
Early-phase response:

Furthermore, in ______ :
Bronchial contraction, wheezing, cough, dyspnea, and hypoxemia as a result of mast cell degranulation and histamine release.

Bronchodilators can reverse bronchospasm

A

asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Phases of the Inflam Response Early-phase response: Furthermore, in asthma : _____ _____, wheezing, cough, dyspnea, and hypoxemia as a result of mast cell degranulation and histamine release.
Bronchial contraction
26
Phases of the Inflam Response Early-phase response: Furthermore, in asthma : Bronchial contraction, _______, cough, dyspnea, and hypoxemia as a result of mast cell degranulation and histamine release.
wheezing
27
Phases of the Inflam Response Early-phase response: Furthermore, in asthma : Bronchial contraction, wheezing, _____, dyspnea, and hypoxemia as a result of mast cell degranulation and histamine release.
cough
28
Phases of the Inflam Response Early-phase response: Furthermore, in asthma : Bronchial contraction, wheezing, cough,______ and hypoxemia as a result of mast cell degranulation and histamine release.
dyspnea,
29
Phases of the Inflam Response Early-phase response: Furthermore, in asthma : Bronchial contraction, wheezing, cough, dyspnea, and ______ as a result of mast cell degranulation and histamine release.
hypoxemia
30
Phases of the Inflam Response Early-phase response: Furthermore, in asthma : Bronchial contraction, wheezing, cough, dyspnea, and hypoxemia as a result of ____ ____ ______ and histamine release.
mast cell degranulation
31
Phases of the Inflam Response Early-phase response: Furthermore, in asthma : Bronchial contraction, wheezing, cough, dyspnea, and hypoxemia as a result of mast cell degranulation and ______ _______
histamine release.
32
Phases of the Inflam Response _____-____ response: Develops 6 to 8 hours later. Much more difficult to resolve than early-phase response. Treatment is aimed at stopping inflammatory progression before it occurs at this stage. Hypersecretion of mucus. Increased vascular permeability.
Late Phase
33
Phases of the Inflam Response Late-phase response: Develops ___-___ ____ later. Much more difficult to resolve than early-phase response.
6 to 8 hours
34
Whats more difficult to resolve late phase or early phase?
Late Phase
35
Phases of the Inflam Response Late-phase response: _______ of mucus. Increased vascular permeability
Hypersecretion
36
Phases of the Inflam Response Late-phase response: Treatment is aimed at stopping inflammatory progression ____ it occurs at this stage.
Before
37
Phases of the Inflam Response Late-phase response: Hypersecretion of mucus. ______ vascular permeability
Increased
38
Phases of the Inflam Response Late-phase response: Hypersecretion of mucus. Increased vascular_______
permeability
39
Phases of the Inflam Response Late-phase response: Hypersecretion of mucus. Increased ______ permeability
vascular
40
Phases of the Inflamm Response _____ _____ Leukotrienes and prostaglandins are released.
Mucus plugging.
41
Phases of the Inflamm Response Mucus plugging. _______ and prostaglandins are released.
Leukotrienes
42
Phases of the Inflamm Response Mucus plugging. Leukotrienes and ______ are released.
prostaglandins
43
Phases of the Inflamm Response Mucus plugging. Leukotrienes and prostaglandins are_______
released.
44
Treatment for allergic asthma. Blocks the initial immune response and the _______ process.
inflammatory
45
Treatment for allergic asthma. Blocks the initial ____ _____ and the inflammatory process.
immune response
46
______: Local dilation of blood | vessels, occurring in seconds
Redness
47
Redness: Local dilation of blood | vessels, occurring in _____
seconds
48
_____: Reddish color several centimeters from the site, occurring 15 to 30 seconds after injury
Flare
49
Flare: Reddish color several centimeters from the site, occurring ___-____ seconds after injury
15 to 30
50
____: Local swelling, occurring in | minutes
Wheal
51
Wheal: _____ _____, occurring in | minutes
Local swelling
52
Wheal: Local swelling, occurring in | _____
minutes
53
______ vascular permeability: An exudate is formed in the surrounding tissues
increased
54
Increased vascular permeability: An exudate is formed in the ______ _______
surrounding tissues
55
_______ infiltration: White cells emigrate through capillary walls (diapedesis) in response to attractant chemicals (chemotaxis)
Leukocytic
56
leukocytic infiltration: ____ ____ emigrate through capillary walls (diapedesis) in response to attractant chemicals (chemotaxis)
White cells
57
leukocytic infiltration: White cells emigrate through_____ _____ (diapedesis) in response to attractant chemicals (chemotaxis)
capillary walls
58
leukocytic infiltration: White cells emigrate through capillary walls (_______) in response to attractant chemicals (chemotaxis)
diapedesis
59
leukocytic infiltration: White cells emigrate through capillary walls (diapedesis) in response to attractant chemicals (______)
chemotaxis
60
______: White cells and macrophages (in the lungs) ingest and process foreign material such as bacteria
Phagocytosis
61
Phagocytosis: _______ and ______ (in the lungs) ingest and process foreign material such as bacteria
White cells; macrophages
62
Phagocytosis: White cells and macrophages (in the lungs)_____ and process foreign material such as bacteria
ingest
63
_____ _____: Histamine and chemoattractant factors are released at the site of injury, and various inflammatory mediators such as complement and arachidonic acid products are generated
Mediator cascade
64
Mediator cascade: _______ and chemoattractant factors are released at the site of injury, and various inflammatory mediators such as complement and arachidonic acid products are generated
Histamine
65
``` Mediator cascade: Histamine and _______ factors are released at the site of injury, and various inflammatory mediators such as complement and arachidonic acid products are generated ```
chemoattractant
66
Mediator cascade: Histamine and chemoattractant factors are released at the site of injury, and various inflammatory mediators such as _____ and arachidonic acid products are generated
complement
67
Mediator cascade: Histamine and chemoattractant factors are released at the site of injury, and various inflammatory mediators such as complement and _____ ______ products are generated
arachidonic acid
68
Most common inflammation in the airway
Chronic Bronchitis | Asthma
69
``` Treatment with antiinflammatory agents such as _______ is important to reduce the basal level of airway inflammation and thereby reduce airway hyperresponsiveness and the predisposition to acute episodes of obstruction ```
glucocorticoids
70
``` Treatment with antiinflammatory agents such as glucocorticoids is important to reduce the _____ level of airway inflammation and thereby reduce airway hyperresponsiveness and the predisposition to acute episodes of obstruction ```
basal
71
``` Treatment with antiinflammatory agents such as glucocorticoids is important to reduce the basal level of airway inflammation and thereby reduce airway ________ and the predisposition to acute episodes of obstruction ```
hyperresponsiveness
72
``` Treatment with antiinflammatory agents such as glucocorticoids is important to reduce the basal level of airway inflammation and thereby reduce airway hyperresponsiveness and the _______ to acute episodes of obstruction ```
predisposition
73
``` Treatment with antiinflammatory agents such as glucocorticoids is important to reduce the basal level of airway inflammation and thereby reduce airway hyperresponsiveness and the predisposition to _____ episodes of obstruction ```
acute
74
Assess for presence of side effects of inhaled steroid therapy ``` Oral thrush Hoarseness Voice changes cough/wheezing with MDI Use of reservoir with MDI ```
killl meeee
75
Assess for presence of side effects of inhaled ______ therapy ``` Oral thrush Hoarseness Voice changes cough/wheezing with MDI Use of reservoir with MDI ```
steroid
76
Assess for presence of side effects of inhaled steroid therapy ``` _____ _____ Hoarseness Voice changes cough/wheezing with MDI Use of reservoir with MDI ```
Oral thrush
77
Assess for presence of side effects of inhaled steroid therapy ``` Oral thrush Hoarseness ___ _______ cough/wheezing with MDI Use of reservoir with MDI ```
Voice changes
78
Assess for presence of side effects of inhaled steroid therapy ``` Oral thrush _______ Voice changes cough/wheezing with MDI Use of reservoir with MDI ```
Hoarseness
79
Assess for presence of side effects of inhaled steroid therapy ``` Oral thrush Hoarseness Voice changes ______/____ with MDI Use of reservoir with MDI ```
cough/wheezing
80
Assess for presence of side effects of inhaled steroid therapy ``` Oral thrush Hoarseness Voice changes cough/wheezing with MDI Use of ______ with MDI ```
reservoir
81
_______ Side effects ``` Renal insufficiency Extrapulmonary allergy Acute asthma HPA suppression (minimal) Growth retardation Osteoporosis ```
SYSTEMIC
82
SYSTEMIC ``` _____ _______ Extrapulmonary allergy Acute asthma HPA suppression (minimal) Growth retardation Osteoporosis ```
Renal insufficiency
83
SYSTEMIC ``` Renal insufficiency Extrapulmonary allergy _____ asthma HPA suppression (minimal) Growth retardation Osteoporosis ```
Acute
84
SYSTEMIC ``` Renal insufficiency ______ allergy Acute asthma HPA suppression (minimal) Growth retardation Osteoporosis ```
Extrapulmonary
85
SYSTEMIC ``` Renal insufficiency Extrapulmonary allergy Acute asthma ____suppression (minimal) Growth retardation Osteoporosis ```
HPA
86
SYSTEMIC ``` Renal insufficiency Extrapulmonary allergy Acute asthma HPA ________ (minimal) Growth retardation Osteoporosis ```
suppression
87
SYSTEMIC ``` Renal insufficiency Extrapulmonary allergy Acute asthma HPA suppression (_____) Growth retardation Osteoporosis ```
minimal
88
SYSTEMIC ``` Renal insufficiency Extrapulmonary allergy Acute asthma HPA suppression ____ ________ Osteoporosis ```
Growth retardation
89
SYSTEMIC ``` Renal insufficiency Extrapulmonary allergy Acute asthma HPA suppression (_____) Growth retardation _________ ```
Osteoporosis
90
______ Side Effects Oropharyngeal fungal infections Dysphonia Cough, bronchoconstriction Incorrect use of MDI
LOCAL
91
LOCAL Side Effects _______ fungal infections Dysphonia Cough, bronchoconstriction Incorrect use of MDI
Oropharyngeal
92
LOCAL Side Effects Oropharyngeal fungal infections ________ Cough, bronchoconstriction Incorrect use of MDI
Dysphonia
93
LOCAL Side Effects Oropharyngeal ______ infections Dysphonia Cough, bronchoconstriction Incorrect use of MDI
fungal
94
LOCAL Side Effects Oropharyngeal fungal infections Dysphonia Cough, __________ Incorrect use of MDI
bronchoconstriction
95
LOCAL Side Effects Oropharyngeal fungal infections Dysphonia ______, bronchoconstriction Incorrect use of MDI
Cough
96
LOCAL Side Effects Oropharyngeal fungal infections Dysphonia Cough, bronchoconstriction _____ use of MDI
Incorrect
97
LOCAL Side Effects Oropharyngeal fungal infections Dysphonia Cough, bronchoconstriction Incorrect use of ____
MDI
98
_____ suppression not seen in doses | < 800 ug
Adrenal
99
Adrenal _______ not seen in doses | < 800 ug
suppression
100
Adrenal suppression not seen in doses | < ____ __
800 ug
101
Evidence of a beneficial, ___________ interaction between glucocorticoids and β- adrenergic agonists
complementary
102
Evidence of a beneficial, complementary interaction between_______ and β- adrenergic agonists
glucocorticoids
103
Evidence of a beneficial, complementary | interaction between glucocorticoids and____-_____ ______
β-adrenergic agonists
104
_____ increase β2-adrenergic receptor | transcription
Steroids
105
Steroids_____ β2-adrenergic receptor | transcription
increase
106
Steroids increase____-_____ receptor | transcription
β2-adrenergic
107
steroids increase β2-adrenergic receptor | ______
transcription
108
______ corticosteroid therapy can provide partial protection against development of tolerance
Inhaled
109
Inhaled corticosteroid therapy can provide _____ _____ against development of tolerance
partial protection
110
Inhaled corticosteroid therapy can provide partial protection against development of _____
tolerance
111
_______ has been shown to promote binding of the glucocorticoid receptor to the response element of the cell’s nuclear DNA
Salmeterol
112
Salmeterol has been shown to promote _____ of the glucocorticoid receptor to the response element of the cell’s nuclear DNA
binding
113
Salmeterol has been shown to promote binding of the_______ receptor to the response element of the cell’s nuclear DNA
glucocorticoid
114
Salmeterol has been shown to promote binding of the glucocorticoid receptor to the response element of the cell’s ____ _____
nuclear DNA
115
Salmeterol has been shown to promote binding of the glucocorticoid receptor to the ______ element of the cell’s nuclear DNA
response
116
______ corticosteroids All of the steroids available as orally inhaled agents are also available in an intranasal formulation
Intranasal
117
Intranasal corticosteroids All of the steroids available as____ ____ agents are also available in an intranasal formulation
orally | inhaled
118
``` Used for treatment of allergic or inflammatory nasal conditions and seasonal or perennial allergic or nonallergic rhinitis and to prevent reoccurrence of nasal polyps ```
Intranasal corticosteroids
119
Systemic administration of ______ ``` Suppression of the HPA axis immunosuppression Psychiatric reactions Cataract formation Myopathy of striated skeletal muscle Peptic ulcer ```
steroids
120
Systemic administration of steroids ``` Suppression of the___ ___ immunosuppression Psychiatric reactions Cataract formation Myopathy of striated skeletal muscle Peptic ulcer ```
HPA axis
121
Systemic administration of steroids ``` Suppression of the HPA axis _________ Psychiatric reactions Cataract formation Myopathy of striated skeletal muscle Peptic ulcer ```
immunosuppression
122
Systemic administration of steroids ``` Suppression of the HPA axis immunosuppression ______ reactions Cataract formation Myopathy of striated skeletal muscle Peptic ulcer ```
Psychiatric
123
Systemic administration of steroids ``` Suppression of the HPA axis immunosuppression Psychiatric reactions Cataract formation Myopathy of striated skeletal muscle ____ ____ ```
Peptic ulcer
124
Systemic side effects with _____ administration Of major concern: HPA suppression Loss of bone density Growth restriction in children
aerosol
125
Systemic side effects with aerosol administration Of major concern: ____ ______ Loss of bone density Growth restriction in children
HPA suppression
126
Systemic side effects with aerosol administration Of major concern: HPA suppression _____ ___ ____ ____ Growth restriction in children
Loss of bone density
127
Systemic side effects with aerosol administration Of major concern: HPA suppression Loss of bone density _____ _____ _____ _____
Growth restriction in children
128
Clinical Application of Aerosol _____ Use in asthma Early use in asthma For acute severe asthma Clinical use of inhaled corticosteroids
Steroids
129
``` Clinical Application of Aerosol Steroids Use in_____ Early use in asthma For acute severe asthma Clinical use of inhaled corticosteroids ```
asthma
130
``` Clinical Application of Aerosol Steroids Use in asthma Early use in asthma For acute severe asthma Clinical use of inhaled ______ ```
corticosteroids
131
Clinical Application of Aerosol Steroids Use in _____ Relieves symptoms Little or no effect on FEV1
COPD
132
Clinical Application of Aerosol Steroids Use in copd Relieves symptoms Little or no effect on _____
FEV!
133
Inahled corticosteroid Controller or Rescue
Controller
134
Steroid Dependency | Classified into two forms:
Physiologic - Psychological
135
___________—Desire occurs because of an induced sense of well-being or effective symptom relief when taking the drug.
Psychological
136
________ —Steroid suppression of the normal functions of the HPA occurs when a patient is withdrawn from steroids too quickly.
Physiologic